EndoGastric Solutions announces 12-Month TEMPO study data confirms TIF procedure dramatically eliminates GERD symptoms in majority of patients

06-05-2014 Business Wire HealthComments (0)

BiotechnologyGastro-intestinalsUSA

EndoGastric Solutions (EGS), a leader in endoluminal reconstructive treatment for gastroesophageal reflux disease (GERD), today announced that new data show that a vast majority of patients with GERD who underwent the Transoral Incisionless Fundoplication (TIF) procedure with the EsophyX device continued to report complete elimination of all troublesome regurgitation and esophagitis for a full year after the procedure. This new 12-month analysis of the prospective,

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top